These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 37495949

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a prospective control trial].
    Yang WY, Liu TF, Chen XJ, Guo Y, Li T, Qi BQ, Liu F, Chang LX, Ruan M, Liu XM, Zhang L, Zou Y, Chen YM, Zhu XF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1172-1177. PubMed ID: 33172550
    [Abstract] [Full Text] [Related]

  • 23. Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
    Schwartzberg LS, Bhat G, Peguero J, Agajanian R, Bharadwaj JS, Restrepo A, Hlalah O, Mehmi I, Chawla S, Hasal SJ, Yang Z, Cobb PW.
    Oncologist; 2020 Aug; 25(8):e1233-e1241. PubMed ID: 32476162
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
    Shi YK, Feng FY, Sun Y.
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):739-42. PubMed ID: 7541325
    [Abstract] [Full Text] [Related]

  • 29. Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial.
    Wang C, Zhu S, Miao C, Wang Y, Chen J, Yuan S, Hu X.
    BMC Cancer; 2022 May 13; 22(1):542. PubMed ID: 35562713
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia.
    Qin Y, Han X, Wang L, Du P, Yao J, Wu D, Song Y, Zhang S, Tang L, Shi Y.
    Chin J Cancer Res; 2017 Oct 13; 29(5):402-410. PubMed ID: 29142459
    [Abstract] [Full Text] [Related]

  • 32. Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study.
    Huang J, Zhu J, Jiang L, Xu J, Lin X, Chang J, Zhang X, Lu S, Sun F, Wang J, Que Y, Ye Z, Yang L, Yuan X, Cai W, Tian C, Wu Y, He X, Tang YL, Zhang Y.
    Front Pharmacol; 2024 Oct 13; 15():1419369. PubMed ID: 39086394
    [Abstract] [Full Text] [Related]

  • 33. Pegylated recombinant human granulocyte colony-stimulating factor regulates the immune status of patients with small cell lung cancer.
    Sun J, Bai H, Wang Z, Duan J, Li J, Guo R, Wang J.
    Thorac Cancer; 2020 Mar 13; 11(3):713-722. PubMed ID: 32020764
    [Abstract] [Full Text] [Related]

  • 34. Factors Associated with Absolute Neutrophil Count Dynamics and Docetaxel-Adryamicin-Cyclophosphamide (TAC) Chemotherapy Induced Neutropenia During Extended Filgrastim Administration in Breast Cancer Patients.
    Ashariati A, Bintoro UY, Savitri M, Diansyah MN, Amrita PNA, Romadhon PZ, Wijaya AY, Hendrata WM, Looi SS, Mahmudin AA.
    Acta Med Indones; 2022 Jul 13; 54(3):371-378. PubMed ID: 36156473
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor in children with acute leukaemia.
    Liu XT, Zhao YX, Jia GW, Yang F, Zhang CZ, Han B, Dai JH, Han YQ, Tang BH, Yang XM, Shi HY, Zhou Y, Sui ZG, Chen JZ, van den Anker JN, Zhao W.
    Br J Clin Pharmacol; 2021 Aug 13; 87(8):3292-3300. PubMed ID: 33506975
    [Abstract] [Full Text] [Related]

  • 36. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P, Milazzo S, Liu JP, Zwahlen M, Birkmann J, Horneber M.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD007913. PubMed ID: 23076939
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative study on the efficacy and safety between pegfilgrastim (PEG-rhG-CSF) and recombinant human granulocyte colony-stimulating factor in promoting hematopoietic recovery after allogeneic hematopoietic stem cell transplantation after hematological malignancy].
    Yang F, Sun XD, Yuan L, Zhang JC, Hu JW, Liu N, Lou X, Su YF, Yu ZY, Chen JL, Li YH, Hu LD, Chen H, Jiang M.
    Zhonghua Xue Ye Xue Za Zhi; 2017 Oct 14; 38(10):831-836. PubMed ID: 29166733
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
    Hu C, Ji B, Hu X, Yang C, Sun W, Zhao X, Li L, Li X, Zhang L.
    Clin Pharmacol Drug Dev; 2021 Mar 14; 10(3):291-298. PubMed ID: 32567217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.